A clinical cohort study of early-stage serum biological early warning markers in children with autism spectrum disorder

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000035174

Enrollment

Unknown

Registered

2020-08-02

Start date

2020-09-01

Completion date

Unknown

Last updated

2020-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism Spectrum Disorder

Interventions

Case group:None

Healthy children:Nil

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Newborns born in the obstetrics department of Shenzhen Second People's Hospital from September 2020 to September 2021 (gestational age 33-42 weeks; birth weight 2000g-4000g); 2. The subjects' mothers participated in the study 24-72 hours after delivery; 3. All subjects should sign informed consent before inclusion.

Exclusion criteria

Exclusion criteria: 1. Multiple pregnancy and newborns with major congenital defects; 2. The lost interviewers in the research process.

Design outcomes

Primary

Measure	Time frame
Leptin;Brain-derived neurotrophic factor;weight;Early warning signs of child developmental behavior;	—

Countries

China

Contacts

Public ContactWang Bo

The Shenzhen Second People's Hospital

66286432@qq.com+86 755-83366388-8089

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026